Skip to content

Evaluation and comparison of zinc and omega 3 fatty acids supplementation on leptin level in obese peoples

Evaluation and comparison of zinc and omega 3 fatty acids supplementation on leptin level in obese peoples

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201112222017N5
Enrollment
90
Registered
2012-01-10
Start date
2012-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Obesity due to excess calories

Interventions

Intervention 1: Intervention group1: 2 omega3 capsula with 1 gr weight(containing 180 mg EPA and 110 mg DHA) for 30 day. Intervention 2: 1 zinc pill (containing 30 mg zinc) for 30 day. Interventio
Treatment - Drugs
Intervention group1: 2 omega3 capsula with 1 gr weight(containing 180 mg EPA and 110 mg DHA) for 30 day
1 zinc pill (containing 30 mg zinc) for 30 day
Placebo group: 2 capsule 1 g (containing 30 mg starch) for 30 day

Sponsors

Vice-chancellor for research of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: BMI=30-40 and age 18-45 yrs. Exclusion criteria: Pregnancy and lactation; menopause; medical history of diabetes mellitus, liver, kidney and thyroid disorders; HIV disease; any interfering medication with lipid profile; receiving beta blocker medications, Omega3 fatty acids, vitamin A , iron, zinc and calcium supplementation; weight lowering drugs or special diet in the past 2 months and smoking.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Leptin. Timepoint: Baseline and at the end of intervention. Method of measurement: Radioimmunoassay (kit).

Secondary

MeasureTime frame
Nutritional status. Timepoint: Baseline and at the end of intervention. Method of measurement: Dietary record and food frequency questionnaire.;Plasma Zinc concentration. Timepoint: Baseline and at the end of intervention. Method of measurement: Atomic absorption spectrophotometry.;Appetite level. Timepoint: Baseline and at the end of intervention. Method of measurement: Visual analog scale questionnaire.;Anthropometric measurements. Timepoint: Baseline and at the end of intervention. Method of measurement: Analogue scale and meter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLaleh Payahoo

Tabriz university of medical science

llllpayahoo44@gmail.com+98 41 1335 2295

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026